Have a personal or library account? Click to login
Infections Connected with Organ and Tissue Transplantation Cover

Infections Connected with Organ and Tissue Transplantation

Open Access
|Jul 2024

References

  1. Abad C.L.R., Deziel P.J., Razonable R.R.: Treatment of latent TB infection and the risk of tuberculosis after solid organ transplantation: Comprehensive review. Transpl. Infect. Dis. 21, e13178 (2019)
  2. Aldave A.J., DeMatteo J., Glasser D.B., Tu E.Y., Iliakis B., Nordlund M.L., Misko J., Verdier D.D., Yu F.: Report of the Eye Bank Association of America medical advisory board subcommittee on fungal infection after corneal transplantation. Cornea, 32, 149–1454 (2013)
  3. Andacoglu O.M., Greenstein S.M.: Intestinal transplantation. Mescape, March (2021) https://emedicine.medscape.com/article/1013245
  4. Audet M., Piardi T., Panaro F., Ghislotti E., Gheza F., Cag M., Jarzembowski T.M., Flicoteaux H., Wolf P., Cinqualbre J.: Incidence and clinical significance of bacterial and fungal contamination of the preservation solution in liver transplantation. Transpl. Infect. Dis. 13, 84–88 (2011)
  5. Bachellier P., Addeo P., Saouli A.-C., Woehl-Jaegle M.L., Ellero B., Oussoultzoglou E., Marcellin L.: Candida albicans arteritis transmitted by preservation fluid after liver transplantation. Ann. Transplant. 19, 64–67 (2014)
  6. Belzer F.O., Ashby B.S., Gulyassy P.F., Powell M.: Successful seventeen-hour preservation and transplantation of human-cadaver kidney. N. Engl. J. Med. 278, 608–610 (1968)
  7. Berendsen T., Bruinsma B., Puts C.F., Saeidi N., Usta O.B., Uygun B.E., Izamis M.-L., Toner M., Yarmush M.L., Uygun K.: Supercooling enables long-term transplantation survival following 4 days of liver preservation. Nat. Med. 20, 790–793 (2014)
  8. Berry P.S., Rosenberger L.H., Guidry C.A., Agarwal A., Pelletier S., Sawyer R.G.: Intraoperative versus extended antibiotic prophylaxis in liver transplant surgery: a randomized controlled pilot trial. Liver Transplantation, 25, 1043–1053 (2019)
  9. Bertrand D., Pallet N., Sartorius A., Zahar J.R., Soussan R.S., Lortholary O., Legendre C., Mamzer M.-F.: Clinical and microbial impact of screening kidney allograft preservative solution for bacterial contamination with high-sensitivity methods. Transpl. Int. 26, 795–799 (2013)
  10. Bodro M., Sabé N., Tubau F., Llado L., Baliellas C., Roca J., Cruzado J.M., Carratala J.: Risk factors and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in solid-organ transplant recipients. Transplantation, 96, 843–849 (2013)
  11. Botta, D.M., Mancini, M.C. Heart transplantation. Medscape June (2023) https://emedicine.medscape.com/article/429816
  12. Botterel F., Foulet F., Legrand P., Soria A.-M., Farrugia C., Grimbert P., Matignon M., Lauzet J.-Y., Guerrini P., Bretagne S.: Yeast contamination of kidney, liver and cardiac preservation solutions before graft: need for standardization of microbial evaluation. J. Hosp. Infect. 76, 52–55 (2010)
  13. Calne R.Y., Pegg D.E., Pryse-Davies J., Brown F.L.: Renal preservation by ice-cooling: an experimental study relating to kidney transplantation from cadavers. Br. Med. J. 2, 651–655 (1963)
  14. Centers for Disease Control and Prevention (CDC): Transmission of Strongyloides stercoralis through transplantation of solid organs-Pennsylvania, 2012. MMWR 62, 264–266 (2013)
  15. Cervera C., Van Delden C., Gavaldà J., Welte T., Akova M., Carratalà J.: Multidrug-resistant bacteria in solid organ transplant recipients. Clin. Microbiol. Infect. 2014, 20(Suppl. 7), 49–73 (2014)
  16. Chaim F.H.M., Boin I.F.S.F., Ataide E.C., Stucchi R.S.B.: Perfusion fluid contamination in relation to recipient survival and acute cellular rejection in orthotopic liver transplantation: retrospective analysis. Transplant. Proc. 43, 1313–1315 (2011)
  17. Chaurasia S., Das S., Roy A.: A review of long-term corneal preservation techniques. Indian J. Ophthalmol. 68, 1357–1363 (2020)
  18. Chu W.: The past twenty-five years in eye banking. Cornea 19, 754–765 (2000)
  19. Collins G.M., Bravo-Shugarman M., Terasaki P.I.: Kidney preservation for transportation. Initial perfusion and 30 h’ ice storage. Lancet, 2, 1219–1222 (1969)
  20. Collins B.H.: Kidney transplantation. Mescape, December (2021) https://emedicine.medscape.com/article/430128
  21. Colvara Mattana A.M., Rodrigues Marra A., de Oliveira Machado A.M., de Jesus Lopes Filho G., Salzedas Netto A.A., Miziara Gonzalez A.: Evaluation of the presence of microorganisms in solid-organ preservation solution. Braz. J. Infect. Dis. 15, 528–532. (2011)
  22. Corbel A., Ladrière M., Le Berre N., Durin L., Rousseau H., Frimat L., Thilly N., Pulcini C.: Microbiological epidemiology of preservation fluids in transplanted kidney: a nationwide retrospective observational study. Clin. Microbiol. Infect, 26, 475–484 (2020)
  23. Crawford A.Z., Patel D.V., McGhee C.N.: A brief history of corneal transplantation: from ancient to modern. Oman J. Ophthalmol. 6(Suppl. 1), S12–S17 (2013)
  24. Datta S., Fitzpatrick A.M., Haykal S.: Preservation solutions for attenuation of ischemia-reperfusion injury in vascularized composite allotransplantation. SAGE Open Medicine, 9, 1–13 (2021)
  25. Deogaonkar K. and Roy A.: Donor related corneal graft infection: a review of literature and preventive strategies. Semin. Ophthalmol. 38, 219–225 (2023)
  26. Elliott G.D., Wang S., Fuller B.J.: Cryoprotectants: a review of the actions and applications of cryoprotective solutes that modulate cell recovery from ultra-low temperatures. Cryobiology, 76, 74–91 (2017)
  27. European Committee (Partial Agreement) on Organ Transplantation of the Council of Europe (CD-P-TO: Guide to the quality and safety of organs for transplantation. 8th edition. European Directorate for the Quality of Medicines & HealthCare, Council of Europe, Strasbourg, France, 2022
  28. European Eye Bank Association: Past, Present, and Future. https://eyebankingjournal.org/wp-content/uploads/2015/12/26-339-1-PB.pdf
  29. European Eye Bank Association – EEBA Technical guidelines for ocular tissue. (2020) https://www.eeba.eu/files/pdf/EEBA_ Technical_Guidelines_for_Ocular_Tissue_Revision11.pdf
  30. European Pharmacopoeia 11, 2.6.1. Sterility. (04/201:20601). European Directorate for the Quality of Medicines & HealthCare, Council of Europe, Strasbourg, France, 2023
  31. European Pharmacopoeia 11, 2.6.39. Microbiological Examination of Human Tissues. (01/2023:20639). European Directorate for the Quality of Medicines & HealthCare, Council of Europe, Strasbourg, France, 2023
  32. Eye Bank Association of America (EBAA) 2021. https://restoresight.org/
  33. Fabre L., Puyraveau M., Jeanvoine A., Thibaud G., Pizzuto J., Pouthier F., Delbosc B., Gauthier A.S.: Changes of contamination rate and microorganism evaluation in organ-cultured human corneas: a 14-year review from a French Regional Eye Bank. Cornea 40, 696–703 (2021)
  34. Finger E.B., Namsrai B.-E., Rao J.S.: Organ preservation. Medscape. October (2023) https://emedicine.medscape.com/article/431140-overview#showall
  35. Fishman J.A.: Infection in organ transplantation. Am. J. Transplant. 17, 856–879 (2017)
  36. Free R.J., Levi M.E., Bowman J.S., Bixler D., Brooks J.T., Buchacz K., Moorman A., Berger J., Basavaraju S.V.: Updated U.S. Public Health Service guideline for testing of transplant candidates aged < 12 years for infection with HIV, Hepatitis B virus, and Hepatitis C virus – United States, MMWR, 71, 844–846 (2022)
  37. Garcia-Zamora C. & Parrilla Paricio P. et al.: Clinical significance of contamination of the preservation solution in liver transplantation. Transplant. Proc. 47, 2322–2323 (2015)
  38. Gibbons A., Leung E.H., Yoo S.H.: Cost-effectiveness of anti-fungal supplementation of corneal cold storage media. Ophthalmology, 127, 582–88 (2020)
  39. Gimenes I., Pintor A.V.B., da Silva Sardinha M., Marañón-Vásquez G.A., Gonzalez M.S., Presgrave O.A.F., Maia L.C., Alves G.G.: Cold storage media versus Optisol-GS in the preservation of corneal quality for keratoplasty: a systematic review. Appl. Sci. 12, 7079 (2022)
  40. Giwa S. & Toner M. et al.: The promise of organ and tissue preservation to transform medicine. Nat. Biotechnol. 35, 530–542 (2017)
  41. Grossi P.A.: Donor-derived infections, lessons learnt from the past, and what is the future going to bring us. Curr. Opin. Organ Transplant. 23, 417–422 (2018)
  42. Guibert E.F., Petrenko A.Y., Balaban C.L., Somov A.Y., Rodriguez J.V., Fuller B.J.: Organ preservation: current concepts and new strategies for the next decade. Transfus. Med. Hemother. 38, 125–142 (2011)
  43. Hyun J.H. & Kang J.-M. et al.: Changes in tuberculosis risk after transplantation in the setting of decreased community tuberculosis incidence: a national population-based study, 2008–2020. Ann. Clin. Microbiol. Antimicrob. 23,1 (2024)
  44. Jang T.H., Park S.C., Yang J.H., Kim J.Y., Seok J.H., Park U.S., Choi C.W., Lee S.R., Han J.: Cryopreservation and its clinical applications. Integr. Med. Res. 6, 12–18 (2017)
  45. Jing L., Yao L., Zhao M., Peng L-P., Liu M.: Organ preservation: from the past to the future. Acta Pharmacol. Sin. 39, 845–857 (2018)
  46. Jones G.L.A., Dekaris I., Hjortdal J., Pels E. European Eye Bank Association: past, present, and future. Int. J. of Eye Bank. 1, 1–6 (2012) https://eyebankingjournal.org/article/european-eye-bank-association-past-present-future/ https://www.eeba.eu/home
  47. Jones J.M., Kracalik I., Levi M.E., Bowman J.S., Berger J.J., Bixler D., Buchacz K., Moorman A., Brooks J.T., Basavaraju S.V.: Assessing solid organ donors and monitoring transplant recipients for Human Immunodeficiency Virus, Hepatitis B virus, and Hepatitis C virus infection – U.S. Public Health Service guideline, 2020. MMWR Recomm. Rep. 69, 1–16 (2020)
  48. Kelly E.J., Oliver M.A., Carney B.C., Shupp J.W.: Infection and burn injury. Eur. Burn J. 3, 165–179 (2022)
  49. Kieslichova E., Protus M., Nemcova D., Uchytilova E.: Single multidrug resistant Enterobacteriacae donor-derived infection in four solid organ transplant recipients: a case report. BMC Surgery, 19, 111 (2019)
  50. Latchana N., Peck J.R., Whitson B.A., Henry M.L., Elkhammas E.A., Black S.M.: Preservation solutions used during abdominal transplantation: current status and outcomes. World J. Transplant. 5, 154–164 (2015)
  51. Layer N., Cevallos V., Maxwell A.J., Hoover C., Keenan J.D., Jeng B.H.: Efficacy and safety of antifungal additives in Optisol-GS corneal storage medium. JAMA Ophthalmol. 132, 832–837 (2014)
  52. Le Berre N., Ladrière M., Corbel A., Remen T., Durin L., Frimat L., Thilly N., Pulcini C.: Antibiotic therapy in case of positive cultures of kidney transplant preservation fluid: a nationwide survey of prescribing practices. Eur. J. Clin. Microbiol. Infect. Dis. 39, 915–921 (2020)
  53. Len O., Garzoni C., Lumbreras C., Molina I., Meije Y., Pahissa A., Grossi P.: Recommendations for screening of donor and recipient prior to solid organ transplantation and to minimize transmission of donor-derived infections. Clin. Microbiol. Infect. 20(Suppl. 7), 10–18 (2014)
  54. Levesque E., Paugam-Burtz C., Saliba F., Khoy-Ear L., Merle J.-C., Jung B., Stecken L., Ferrandiere M., Mihaila L., Botterel F.: Fungal complications after Candida preservation fluid contamination in liver transplant recipients. Transpl. Int. 28, 1308–1316 (2015)
  55. Li G., Zhu H., Ji C., Zang X.: Microbiological contamination in donor corneas preserved for medium-term. Cell Tissue Bank, 20, 379–387 (2019)
  56. Li J. & Wang C. et al.: The association of organ preservation fluid pathogens with early infection-related events after kidney transplantation. Diagnostics, 12, 2248. (2022)
  57. Ling M.L.H., Wells M., Petsoglou C., Luo, K., Georges P., Devasahayam R., Hodge C., Treloggen J., Sutton G., Zhu M.: Factors affecting corneal organ culture contamination: a 6-year study at the New South Wales Tissue Bank. Cornea, 38, 829–835 (2019)
  58. Louart B., Charles C., Nguyen T.-L., Builles N., Roger C., Lefrant J.-Y., Vachiery-Lahaye F., De Vos J., Couderc G., Muller L.: Microbial contamination and tissue procurement location: A conventional operating room is not mandatory. An observational study. PLoS ONE 14, e0210140 (2019)
  59. Malinis M., Boucher H.W.: Screening of donor and candidate prior to solid organ transplantation – guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin. Transplant. 33, e13548 (2019)
  60. Malinis M., Koff A.: Mycobacterium tuberculosis in solid organ transplant donors and recipients. Curr. Opin. Organ Transplant. 26, 432–439 (2021)
  61. Manuel O., Van den Bogaart L., Mueller N.J., Neofytos D.: Which trial do we need? Culture of preservation fluid in abdominal organ transplant recipients. Clin. Microbiol. Infect. 29, 832–834 (2023)
  62. Manzarbeitia C., Arvelakis A.: Liver transplantation. Mescape, April (2022) https://emedicine.medscape.com/article/431783
  63. Mathes K.J., Tran K.D., Mayko Z.M., Stoeger C.G., Straiko M.D., Terry M.A.: Reports of post-keratoplasty infections for eye bank prepared and non-eye bank-prepared corneas. Cornea, 38, 263–267 (2019)
  64. Mattner F., Kola A., Fischer S., Becker T., Haverich A., Simon A., Suerbaum S., Gastmeier P., Weissbrodt H., Strüber M.: Impact of bacterial and fungal donor organ contamination in lung, heartlung, heart and liver transplantation. Infection, 36, 207–212 (2008)
  65. Meier R.P.H. & Berney T. et al.: Pancreas preservation fluid microbial contamination is associated with poor islet isolation outcomes – a multi-centre cohort study. Transpl. Int. 31, 917–929 (2018)
  66. Merrill JP, Murray JE, Harrison JH, Guild WR. Successful homotransplantation of the human kidney between identical twins. JAMA. 160, 277–282 (1956)
  67. Mistò R., Giurgola L., Pateri F., Limongelli A., Ragazzi E., D’Amato Tóthóva J.: A new storage medium containing amphotericin B versus Optisol-GS for preservation of human donor corneas. British J. Ophthalmol. 106, 184–189 (2020)
  68. Mullane K.M., Dubberke E.R.: AST ID Community of Practice: Management of Clostridioides (formerly Clostridium) difficile infection (CDI) in solid organ transplant recipients: Guidelines from the American Society of Transplantation Community of Practice. Clin. Transplant. 33, e13564 (2019)
  69. Nguyen Van R. & Tattevin P. et al.: Characteristics, management, and outcome of tuberculosis after liver transplant: a case series and literature review. Infect. Dis. Now, 54, 104869 (2024)_
  70. Oli A.N., Babajide Rowaiye A., Adejumo S.A., Anazodo F.I., Ahmad R., Sinha S., Haque M., Adnan N.: Classic and current opinions in human organ and tissue transplantation. Cureus, 14, e30982 (2022)_
  71. ONT-WHO Global Observatory on Donation and Transplantation. https://www.transplant-observatory.org/summary/
  72. Oriol I., Lladó L., Vila M., Baliellas C., Tubau F., Sabé N., Fabregat J., Carratalàet J.: The etiology, incidence, and impact of preservation fluid contamination during liver transplantation. PLoS ONE, 11, e0160701 (2016)
  73. Oriol I., Sabé N., Tebé C., Veroux M., Boin F.S.F., Carratalà J.: Clinical impact of culture-positive preservation fluid on solid organ transplantation: a systematic review and meta-analysis. Transplant. Rev. 32, 85–91 (2018)
  74. Oriol I. & Carratalà J. et al.: The impact of culturing the organ preservation fluid on solid organ transplantation: a prospective multicenter cohort study. Open Forum Infect. Dis. 6, ofz180 (2019)
  75. Ozgur O.S., Namsrai B.-E., Pruett T.L., Bischof J.C., Toner M., Finger E.B., Uygun K.: Current practice and novel approaches in organ preservation. Front. Transplant. 2, 1156845 (2023)
  76. Paolin A., Montagner G., Petit P., Trojan D.: Contamination profile in allografts retrieved from multi tissue donors: longitudinal analysis. Cell Tissue Bank, 19, 809–817 (2018)
  77. Parasuraman R., Julian K., AST Infectious Diseases Community of Practice: Urinary tract infections in solid organ transplantation. Am. J. Transplant. 13(Suppl. 4), 327–336 (2013)
  78. Peghin M., Graziano E., Grossi P.A.: Skin and soft tissue infections in solid organ transplants. Cur. Opin. Infect. Dis. 37, 112–120 (2024)
  79. Petrenko A., Carnevale M., Somov A., Osorio J., Rodríguez J., Guibert E., Fuller B., Froghi F.: Organ preservation into the 2020s: the era of dynamic intervention. Transfus. Med. Hemother. 46, 151–172 (2019)
  80. Pilmis B., Weiss E., Scemla A., Le Monnier A., Grossi P.A., Slavin M.A., Van Delden C., Lortholary O., Paugam-Burtz C., Zahar J.-R.: Multidrug-resistant Enterobacterales infections in abdominal solid organ transplantation. Clin. Microbiol. Infect. 29, 38–43 (2023)
  81. Ranghino A., Diena D., Simonato F., Messina M., Burdese M., Piraina V., Fop F., Segoloni G.P., Biancone L.: Clinical impact of bacterial contamination of perfusion fluid in kidney transplantation. SpringerPlus 5, 7 (2016)
  82. Rao J.S., Finger E.B.: Pancreas transplantation. Mescape April (2022) https://emedicine.medscape.com/article/429408
  83. Reimondez S., Chamorro M.L., Alcaraz A., Segade E.G., Pereyra R., Marari M., Maraschio M.A.: Preservation fluids cultures, clinical significance in liver transplantation. Medicina (Buenos Aires), 81, 555–558 (2021)
  84. Reticker A., Lichvar A., Walsh M., Gross A.E., Patel S.: Research the significance and impact of screening preservation fluid cultures in renal transplant recipients. Prog. Transplant. 31, 40–46 (2021)
  85. Röck D., Wude J., Bartz-Schmidt K.U., Yoeruek E., Thaler S., Röck T.: Factors influencing the contamination rate of human organ-cultured corneas. Acta Ophthalmol. 95, e706–e712 (2017)
  86. Ruiz P., Gastaca M., Gonzalez J., Hernandez M.J., Ventoso A., Valdivieso A., Montejo M., Ortiz de Urbina J.: Incidence and clinical relevance of bacterial contamination in preservation solution for liver transplantation. Transplant. Proc. 41, 2169–2171 (2009)
  87. Saad E.J. & de la Fuente J. et al.: Infections in the first year after renal transplant. Medicina (Buenos Aires), 80, 611–621 (2020)
  88. Salehi S., Tran K., Grayson W.L.: Advances in perfusion systems for solid organ preservation. Yale J. Biol. Med. 91, 301–312 (2018)
  89. Sauget M., Verdy S., Slekovec C., Bertrand X., Talon D.: Bacterial contamination of organ graft preservation solution and infection after transplantation. Transpl. Infect. Dis. 13, 331–334 (2011)
  90. Sawinski D. and Blumberg E.A.: 40 – Infection in renal transplant recipients. (in) Chronic Kidney Disease, Dialysis, and Transplantation Ed. J. Himmelfarb, T. Alp Ikizler, Elsevier, 2019, 621–638.e6
  91. Sidhu A., Verma G., Humar A., Kumar D.: Outcome of latent tuberculosis infection in solid organ transplant recipients over a 10-year period. Transplantation, 98, 671–675 (2014)
  92. Sotiropoulos G.C., Steinmann J., Stern S., Raduenz S., Machairas N., Rath P.M., Saner F.H., Paul A., Gallinat A.: Donor leucocytosis predicts bacterial and fungal contamination of the preservation solution in visceral organ transplantation. Prog. Transplant. 28, 24–28 (2018)
  93. Sotiropoulos G.C., Kostakis I.D., Prodromidou A., Garoufalia Z., Stamopoulos P., Machairas N.: Contamination of the preservation solution in solid organ. Transplant. Proc. 51, 392–395 (2019)
  94. Southard J.H., Belzer F.O.: Organ preservation. Annu. Rev. Med. 46, 235–247 (1995)
  95. Stern S., Bezinover D., Rath P.-M., Paul A., Saner F.H.: Candida contamination in kidney and liver organ preservation solution: does it matter? J. Clin. Med. 10, 2022 (2021)
  96. Šuca H. & Gál P. et al.: Current approaches to wound repair in burns: how far have we come from cover to close? A narrative review. J. Surg. Res. 296, 383–403 (2024)
  97. Thareja T., Kowalski R., Kamyar R., Dhaliwal D., Jeng B.H., Tu E.: Fungal infection after keratoplasty and the role of antifungal supplementation to storage solution: a review. British J. Ophthalmol. 104, 1036 (2020)
  98. The Nobel Prize in Physiology or Medicine 1990. https://www.nobelprize.org/prizes/medicine/1990/press-release/
  99. Tran-Dinh A. & Montravers P.: Impact of culture-positive preservation fluid on early morbidity and mortality after lung transplantation. Transpl. Int. 36, 10826 (2023)
  100. Tu E.Y.: The rush to supplement: the current case against anti-fungal supplementation of hypothermic corneal storage media. Cornea, 40, 1091–1092 (2021)
  101. UK Standards for Microbiology Investigations, Abdominal organ transport fluid testing. Technical, B62, Issue 1, 2020. NIS, PHE. https://www.rcpath.org/profession/publications/standards-for-microbiology-investigations/bacteriology.html
  102. Veroux M. & Veroux P.: Contamination of preservation fluid in kidney transplantation: single-center analysis. Transplant. Proc. 42, 1043–1045 (2010)
  103. Weissenbacher A., Vrakas G., Nasralla D., Ceresa C.D.L.: The future of organ perfusion and re-conditioning. Transpl. Int. 32, 586–597 (2019)
  104. Whaley D., Damyar K., Witek R.P., Mendoza A., Alexander M., Lakey J.R., Cryopreservation: an overview of principles and cell-specific considerations. Cell Transplant. 30, 963689721999617 (2021)
  105. Whitson, B.A. Lung transplantation. Mescape. April, 2022. https://emedicine.medscape.com/article/429499
  106. WHO Fact Sheet, Burns, 2023 https://www.who.int/news-room/fact-sheets/detail/burns
  107. Yahav D., Manuel O.: Clinical relevance of preservation-fluid contamination in solid-organ transplantation: a call for mounting the evidence. Clin. Microbiol. Infect. 25, 536–537 (2019)
  108. Yansouni C.P., Dendukuri N., Liu G., Fernandez M., Frenette C., Paraskevas S., Sheppard D.C.: Positive cultures of organ preservation fluid predict postoperative infections in solid organ transplantation recipients. Control Hosp. Epidemiol. 33, 672–680 (2012)
  109. Yong L. & Cai C.-J. et al.: Clinical impacts and outcomes with possible donor-derived infection in infected donor liver transplantation: a single-center retrospective study in China. J. Infect. Dis. 221(Suppl. 2), S164–S173 (2020)
  110. Yu X. & Chen J. et al.: Incidence, distribution and clinical relevance of microbial contamination of preservation solution in deceased kidney transplant recipients: a retrospective cohort study from China. Clin. Microbiol. Infect. 25, 595–600 (2019)
  111. Zhang F., Zhong J., Ding H., Liao G.: Effects of preservative fluid associated possible donor-derived carbapenem-resistant Klebsiella pneumoniae infection on kidney transplantation recipients. BMC Nephrology, 23, 101 (2022)
DOI: https://doi.org/10.2478/am-2024-0006 | Journal eISSN: 2545-3149 | Journal ISSN: 0079-4252
Language: English, Polish
Page range: 65 - 80
Submitted on: May 1, 2024
|
Accepted on: Jun 1, 2024
|
Published on: Jul 3, 2024
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2024 Agnieszka E. Laudy, Stefan Tyski, published by Polish Society of Microbiologists
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.